fragment 176-191 & cjc-1295 & ipamorelin CJC 1295/ mod grf 1 29 ipamorelin

Clinical Scenarios Where Ipamorelin Is Sometimes Proposed for Adolescents Despite the absence of evidence, ipamorelin appears in online communities targeting three adolescent scenarios: athletic performance enhancement, body-composition change, and "optimization" in teens with constitutional delay of growth and puberty (CDGP)

GHRH Peptides Side-by-Side Feature Receptor Target Tesamorelin GHRH receptor Sermorelin GHRH receptor CJC-1295 (DAC) GHRH receptor Feature Peptide Length Tesamorelin 44 amino acids (modified) Sermorelin 29 amino acids CJC-1295 (DAC) 29 amino acids + DAC Feature Half-Life Tesamorelin 26-38 minutes Sermorelin 11-12 minutes CJC-1295 (DAC) ~6-8 days Feature Dosing Frequency Tesamorelin Once daily Sermorelin Once nightly CJC-1295 (DAC) 1-2x weekly Feature FDA Status Tesamorelin Approved (2010

Galter D, Mihm S, Droge W

It stimulates blood vessel and nerve outgrowth and increases collagen, elastin, and glycosaminoglycan synthesis